Catalyst Wire Dossier Catalyst Wire Dossier

Peripheral blood autologous CD34+ cell transplantation

CD34+ cell transplantation (autologous, peripheral blood) · Qingdao University
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Peripheral blood autologous CD34+ cell transplantation, covering 2017-04-04 to 2017-04-04. Get the full timeline:

Most recent: Clinical Trial Update: Peripheral Blood Autologous CD34+ Cell Transplantation Promotes Angiogenesis With Atherosclerotic Ischemia for Elderly [NA]

See pricing